BackgroundTo evaluate the effects of intraalveolar placement of gel containing 0.2% chlorhexidine and 10gm of metronidazole on the incidence of alveolar osteitis.Material and MethodsA total of 300 impacted third molars were extracted in 150 patients enrolled in this trial. In each subject a socket was randomly selected and packed to the crest of alveolar ridge with the gel. The contralateral socket was packed with placebo dressing. The occurrence of dry socket was assessed during 3rd and 5th postoperative days .The data was analysed using a meta analytical program. Study Design Double blind, prospective, placebo controlled trial.ResultsThe combination of metronidazole + chlorhexidine gel significantly reduced dry socket incidence from 22.6% to 6.6% (P ≤ 0.001) [McNemar and chi-square tests].ConclusionsThe decrease in incidence of adverse reactions and complications related to local application of metronidazole and chlorhexidine gel explains its clinical use, specifically in mandibular molar extractions where the chances of dry sockets are high.
Key words:Chlorhexidine, dry socket, intra-alveolar, metronidazole, placebo.
Background:Condylar resorption as a cause of relapse after orthognathic surgery is well known. Several authors have presented evidence of the relation between orthognathic surgery and condylar remodeling and resorption. This study was done to appraise the condylar changes along with the form and function following orthognathic surgery, as well as to assess what factors may have contributed to the problems.Methodology:A diagnosis of progressive condylar resorption (PCR) was made by comparison of preoperative and postoperative radiographs (cephalometric radiograms), as well as clinical evaluations. The radiographs were taken for each patient preoperatively and postoperatively, which include immediately after osteotomy, at 6 months and 24 months. Additional radiographs were taken when required. Then, preoperative and postoperative tracings were compared at 24 months postoperatively.Results and Conclusion:It can be concluded from this study that females of relative low age (<18 years) appeared to be a high-risk factor for the occurrence of condylar alteration including PCR. A steep mandibular plane angle, the low facial height ratio (post/ant), and magnitude of surgery were also significantly related to the occurrence of condylar alteration, but the multivariance regression showed that these parameters had only limited value.
Schwannoma or neurilemmoma is a neurogenic tumor. Intraoral schwannoma is rare and intraosseous schwannoma involving maxilla is even rare. We present one such rare case of maxillary sinus schwannoma extending to the nasal cavity, infratemporal fossa in a 22-year-old male. Wide excision of the lesion with subtotal maxillectomy of the right side was done using Weber–Fergusson approach. The patient made a good postoperative recovery. The relevant literature on the presentation, radiology, and management of schwannoma of maxillary sinus is discussed.
We describe a case of an occult fronto temporo parietal meningoencephalocele discovered in a 45 days old infant baby. The most common cause for meningoenphalocele is trauma by any means during birth or during development. But here in our case there is lack of such significant history of trauma and so the possible cause of the lesion may be congenital defect only. Preoperative Clinical, CT and MR images are presented. Lesion was removed surgically with satisfactory post operative recovery. Cite this article as: Sodhi D, Chaudhari KV, Gupta S, Raval R, Shaikh AA, Kapoor A. A case of occult fronto temporo parietal meningoencephalocele in an infant. Int J Med and Dent Sci 2015; 4(2):883-885.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.